相似文献
1
Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cells.
Cancer Lett. 2010 Dec 8;298(2):212-21. doi: 10.1016/j.canlet.2010.07.007. Epub 2010 Jul 31.
2
Icariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signaling.
PLoS One. 2012;7(4):e28706. doi: 10.1371/journal.pone.0028706. Epub 2012 Apr 6.
3
Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.
Haematologica. 2009 May;94(5):638-46. doi: 10.3324/haematol.2008.001933.
4
YM155 induces caspase-8 dependent apoptosis through downregulation of survivin and Mcl-1 in human leukemia cells.
Biochem Biophys Res Commun. 2013 May 24;435(1):52-7. doi: 10.1016/j.bbrc.2013.04.036. Epub 2013 Apr 22.
5
Decursin inhibits growth of human bladder and colon cancer cells via apoptosis, G1-phase cell cycle arrest and extracellular signal-regulated kinase activation.
Int J Mol Med. 2010 Apr;25(4):635-41. doi: 10.3892/ijmm_00000386.
6
[Decursin reduces reactive oxygen species and inhibits cisplatin-induced apoptosis in rat renal tubular epithelial cells].
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2017 Oct;33(10):1328-1334.
7
Brazilein inhibits survivin protein and mRNA expression and induces apoptosis in hepatocellular carcinoma HepG2 cells.
Neoplasma. 2009;56(5):387-92. doi: 10.4149/neo_2009_05_387.
8
Agaritine from Agaricus blazei Murrill induces apoptosis in the leukemic cell line U937.
Biochim Biophys Acta. 2011 May;1810(5):519-25. doi: 10.1016/j.bbagen.2011.02.010. Epub 2011 Mar 5.
9
Decursin prevents cisplatin-induced apoptosis via the enhancement of antioxidant enzymes in human renal epithelial cells.
Biol Pharm Bull. 2010;33(8):1279-84. doi: 10.1248/bpb.33.1279.
10
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Breast Cancer Res. 2007;9(6):R77. doi: 10.1186/bcr1790.
引用本文的文献
1
Decursin induces FLT3-ITD acute myeloid leukemia cell apoptosis by increasing the expression of the ubiquitin-conjugase UBE2L6.
Cell Commun Signal. 2025 Apr 2;23(1):162. doi: 10.1186/s12964-025-02157-4.
2
Anticancer potential of decursin, decursinol angelate, and decursinol from Nakai: A comprehensive review and future therapeutic prospects.
Food Sci Nutr. 2024 Jul 31;12(10):6970-6989. doi: 10.1002/fsn3.4376. eCollection 2024 Oct.
3
Decursin Induces G1 Cell Cycle Arrest and Apoptosis through Reactive Oxygen Species-Mediated Endoplasmic Reticulum Stress in Human Colorectal Cancer Cells in In Vitro and Xenograft Models.
Int J Mol Sci. 2024 Sep 14;25(18):9939. doi: 10.3390/ijms25189939.
4
A comprehensive review of the anticancer effects of decursin.
Front Pharmacol. 2024 Feb 20;15:1303412. doi: 10.3389/fphar.2024.1303412. eCollection 2024.
5
A Natural Organic Compound "Decursin" Has Both Antitumor and Renal Protective Effects: Treatment for Osteosarcoma.
J Oncol. 2023 Dec 14;2023:5445802. doi: 10.1155/2023/5445802. eCollection 2023.
6
Farnesiferol C Induces Apoptosis in Chronic Myelogenous Leukemia Cells as an Imatinib Sensitizer via Caspase Activation and HDAC (Histone Deacetylase) Inactivation.
Int J Mol Sci. 2019 Nov 6;20(22):5535. doi: 10.3390/ijms20225535.
7
Decursin induces apoptosis in glioblastoma cells, but not in glial cells a mitochondria-related caspase pathway.
Korean J Physiol Pharmacol. 2019 Jan;23(1):29-35. doi: 10.4196/kjpp.2019.23.1.29. Epub 2018 Dec 26.
8
Far Infrared Irradiation Enhances Nutraceutical Compounds and Antioxidant Properties in Angelica gigas Nakai Powder.
Antioxidants (Basel). 2018 Dec 11;7(12):189. doi: 10.3390/antiox7120189.
9
Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities.
Molecules. 2017 Dec 7;22(12):2170. doi: 10.3390/molecules22122170.
10
Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases.
Inflamm Res. 2018 Mar;67(3):209-218. doi: 10.1007/s00011-017-1114-7. Epub 2017 Nov 13.
本文引用的文献
1
Survivin and COX-2 expression in male breast carcinoma.
Breast. 2009 Aug;18(4):228-32. doi: 10.1016/j.breast.2009.06.003. Epub 2009 Jul 25.
2
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer.
Ann Oncol. 2009 Apr;20(4):615-20. doi: 10.1093/annonc/mdn693. Epub 2009 Mar 2.
3
Relationship between the expression of cyclooxygenase-2 and survivin in primary pterygium.
Mol Vis. 2009;15:458-63. Epub 2009 Feb 27.
4
[Cardiovascular risk of cyclooxygenase selective inhibitors].
Rev Med Inst Mex Seguro Soc. 2008 May-Jun;46(3):287-99.
5
[Survivin in cancerology : molecular aspects and therapeutic applications].
Med Sci (Paris). 2008 Oct;24(10):821-7. doi: 10.1051/medsci/20082410821.
6
Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics.
Clin Cancer Res. 2008 Aug 15;14(16):5000-5. doi: 10.1158/1078-0432.CCR-08-0746.
7
Targeting survivin in cancer therapy.
Expert Opin Ther Targets. 2008 Apr;12(4):463-76. doi: 10.1517/14728222.12.4.463.
8
Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Breast Cancer Res. 2007;9(6):R77. doi: 10.1186/bcr1790.
9
The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.
Strahlenther Onkol. 2007 Nov;183(11):593-9. doi: 10.1007/s00066-007-1800-4.
10
Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
Biochem Pharmacol. 2007 May 1;73(9):1318-29. doi: 10.1016/j.bcp.2006.12.033. Epub 2007 Jan 5.
Zotero 插件